Mobile Systems as a Challenge for Neurological Diseases Management – The Case of Parkinson\u27s Disease by Laura Pastor-Sanz et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
14 
Mobile Systems as a Challenge 
for Neurological Diseases Management 
– The Case of Parkinson's Disease  
Laura Pastor-Sanz, Mario Pansera, Jorge Cancela, 
Matteo Pastorino and María Teresa Arredondo Waldmeyer 
Life Supporting Technologies, Universidad Politécnica de Madrid 
 Spain 
1. Introduction 
Nowadays the importance of bio-medical engineering and mobile applications for 
healthcare is amazingly growing. During the last decades many devices and technological 
solutions have become available on the market and the interest in applying those 
technologies to the treatment of several kinds of pathologies has consequently increased. 
This chapter addresses the problem of continuous monitoring of patients affected by 
Parkinson’s Disease (PD) and proposes a set of technologies to improve the following and 
management of such subjects.  
PD is a neurodegenerative disorder of the central nervous system that affects motor skills 
and speech (Tolosa, 1998). The primary biochemical abnormality in PD is a deficiency of 
dopamine due to degeneration of neurons in the substantia nigra pars compact (D. G. 
Standaert & Young, 2001). The characteristic motor features of the disease include 
bradykinesia (i.e. slowness of movement), tremor, rigidity (i.e. resistance to externally 
imposed movements), flexed posture, postural instability and freezing of gait. Furthermore, 
PD is usually characterised by the loss of normal prosody of the speech (Darkins et al., 
1988). 
According to the World Health Organisation [WHO], 2002), there are more than six million 
people worldwide affected by PD. The syndrome typically appears around the age of 60. It 
affects Europeans and North Americans more often than Asians or Africans and it is more 
common in men than in women. PD affects about 2% of the population over the age of 65 
years, figure that is expected to double by 2020 (de Lau & Breteler, 2006). For those reasons, 
PD poses a significant public health burden, which is likely to increase in the coming years. 
Annual medical care, including doctors’ visits, physical therapies and treatment for co-
occurring illnesses -such as depression- is estimated at $2,000 to $7,000 for people in early 
stages of the disease, and it is probably much higher for advanced stages. Surgical 
treatments for PD can cost $25,000 or more. As the disease progresses, institutional care at 
an assisted-living facility or nursing home may be required, and the related costs can exceed 
$100,000, per person annually. 
Technology in general and specifically ICT might be an affordable alternative for PD’s 
patients’ treatment and management. The development of platforms for remote health 
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status monitoring, the qualitative and quantitative assessment and treatment 
personalization for people suffering from neurodegenerative diseases is expecting to 
provide in the future a remarkable improvement in patients’ management as well as a 
substantial cutting-off of the economic burden generated by the disease. New technologies 
allow monitoring the evolution of the disease through the employment of a wide range of 
wearable and user-friendly micro-sensors. Moreover, the last advances in data processing 
and data mining algorithms is bound to provide more accurate information about the 
diverse aspects of PD evolution. Finally, it is important to highlight the huge potential in 
costs reduction that such platforms could yield. Furthermore, it is worth mentioning that the 
reduction in costs of hospitalization and treatment represents an attractive asset for the 
market forces involved in the development of biomedical applications.  
2. Treatment  
Current clinical treatment of Parkinson’s disease is performed through ersatz dopamine 
administration or by using Deep Brain Stimulation (DBS) (Singh et al., 2007). 
2.1 Dopamine treatment 
Current therapy is based on augmentation or replacement of dopamine, using the 
biosynthetic precursor levodopa or drugs that activate dopamine receptors. These therapies 
are effective at the beginning of treatment. However, after a variable period of time, this 
initially excellent response is complicated by the appearance of MRCs. Complications 
include wearing-off, the abrupt loss of efficacy at the end of each dosing interval and 
diskinesias (de la Fuente-Fernández et al., 2004). Wearing off and dyskinesias produce 
substantial disability and frequently interfere with medical therapies (A.E. Lang & A.M. 
Lozano, 1998). Usually, motor fluctuations appear first, as a shortening of the initially 
smooth and long lasting dopaminergic response. In the typical case, few hours after drug 
intake the patients start to realize the re-emergence of signs and symptoms of the disease. 
This is known as end of dose deterioration or wearing off. This may happen several times a 
day; therefore the patient may actually several hours per day in the off state (Lees, 1989). 
2.2 Deep brain stimulation 
DBS is a surgical treatment involving the implantation of a medical device called a brain 
pacemaker, which sends electrical impulses to specific parts of the brain (Vaillancourt et al., 
2003). The introduction of DBS as a therapeutic tool for advanced PD has revolutionised the 
clinical management of this condition. Due to its safety profile and efficacy, DBS has 
evolved from a last-resort therapeutic option to a modality that is now routinely offered to 
patients. Over the years, surgical candidates and the outcome expected with this procedure 
has become well established (Deuschl et al., 2006). Overall improvement that might be 
expected with surgery is similar to that provided by levodopa without the associated 
involuntary movements (Group, 2001). As the diseases progresses, however, non-
dopaminergic symptoms (gait, postural instability, sleep disorders and depression, among 
others) become more prominent, leading to a significant increase in morbidity. To overcome 
some of the problems, the use of different surgical targets has been advocated. Perhaps the 
most promising application of DBS on this regards involves the use of Pedunculopontine 
Nucleus (PPN) stimulation for the treatment of gait and postural instability (Mazzone et al., 
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2005). Recent studies suggest that this procedure might be suited for the treatment of falls 
and freezing. In addition to motor symptoms, an improvement in rapid eye movement sleep 
in patient with PD treatment with PPN DBS has been reported (Lim et al., 2009). In the 
future, a tailored approach to patient’s specific symptoms may be possible (Lozano, 2009). 
3. Assessment - state of the art  
The assessment of PD can be performed through clinical and technological methods. Both 
types of solutions are reviewed. 
3.1 Clinical solution  
In Europe, each neurologist or general practitioner (GP) normally cares for 50 to 800 patients 
with PD. The range in workload is a result of diversity both in national health systems and 
in the availability of clinical resources across Europe. Even at 50 patients per clinician, this 
represents a serious challenge to homecare monitoring for specialised conditions. PD’s 
patients normally visit their specialised clinician or GP every 4-6 months. As a result, any 
changes in the patient’s conditions may not be recognised for several months, unless the 
patients themselves make contact (R. Greenlaw et al., 2009).  
In clinical practice, information about motor fluctuations is usually obtained by asking 
patients to recall the number of hours of ON (i.e. when medications effectively attenuate 
tremor) and OFF time (i.e. when medications are not effective). This kind of self–report is 
subject to perceptual bias (e.g. patients often have difficulty distinguishing dyskinesia from 
other symptoms) and recall bias. Another approach is the use of patient diaries, which can 
improve reliability by recording symptoms as they occur, but does not capture many of the 
features useful in clinical decision making (Group, 2001).  
Certainly for PD there is the additional complication of symptoms which vary throughout 
the day (swinging between ON and OFF states). During the short office visit in this 
neurologist the patient may appear very well and he misses to report symptoms of wearing 
off. As a result, treatment modifications are not undertaken in time. Besides, it is 
disempowering for the patient to be asked to present a true picture of their disease in a pre-
scheduled one hour appointment (R. Greenlaw et al., 2009). 
The actual emergence of dyskinesias throughout the day mainly depends on the intermittent 
dopaminergic drug intake, even in influence by timing and quantity of each individual dose 
of levodopa. While other phenomena, such as delayed response or no-response depends 
also on stress, food intake and many other factors. In this case, patients will greatly benefit 
from quantitative objective assessment of their motor status in daily life in relation to the 
dosing schedule. 
In an attempt to solve these problems and to find more objective assessment, several rating 
scales have been designed and used. Among them, the Unified Parkinson’s Disease Rating 
Scale (UPDRS) is the most widely used (Goetz et al., 2004). This rating tried to quantify 
selected symptoms and signs of Parkinsonism in a 5-points scoring system (with 0 for no 
signal and 4 for a marked severity of the sign). Unfortunately, the use of the UPDRS scale, 
like any other semi-objective rating scale presents some limitations like intra and inter 
observer inconsistencies. Besides, it can be time consuming and ca be biased by subjectivity 
issues related to historical information. Moreover, the pattern and severity of PD symptoms 
may vary considerably during the day, while clinical rating scales only provide moment-to 
moment assessment; and finally, measurements of motor fluctuations made in the clinic 
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may not accurately reflect the actual functional disability experienced by the patient at 
home.  
The accurate assessment of speech quality is a major research problem that has attracted 
attention in the field of speech communications for many years. Subjective quality measures 
given by professional personnel who have received special assessment training are 
necessarily time consuming and costly (Lingyun Gu et al., 2005). 
3.2 Technological solution: sensors for motion analysis 
Over the past decades various technologies, methodologies and systems have been 
proposed for the monitoring and the assessment of the Parkinson’s disease. A significant 
number of studies investigated various parameters of the gait of PD patients. Others focused 
on the evaluation and quantification of the patients’ motor status and various disease 
symptoms by the use of computerized motion tests (e.g. handwriting, inserting pegs, and 
games). Table 1 describes some features of the human motion, as well as the characteristics 
which can be measured through the use of wearable sensors. 
 
Features Characteristics Sensor 
Gait  
Speed of Locomotion 
Motion sensor Variability of the gait 
Rigidity of legs 
Posture Trunk inclination Motion sensor 
Leg movement 
Speed Motion sensor 
Motion sensor 
Motion sensor 
Motion sensor 
Length of Step 
Step Frequency 
Stride 
Hand Movement 
Speed Motion sensor 
Motion sensor Angle Amplitude 
Tremor 
Amplitude 
Motion sensor  
Frequency 
Duration 
Asymmetry 
Fall Fall detection Motion sensor 
Freezing of Gait Leg movement analysis Motion sensor 
Levodopa-Induced Dyskinesia 
(LID) 
Duration 
Motion sensor 
Severity 
Bradykinesia 
Duration 
Motion sensor  Severity 
Asymmetry 
Aphasia 
Pitch 
Microphone 
EPE 
Table 1. Parkinson’s disease – wearable sensors for human motion related measurements  
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The accuracy of measurements of the parameters above described depends on several 
technical features that are often in conflict with other needs such as usability, wearability, 
technical feasibility and the social acceptance of the devices used by the subjects.   
In Table 2 a description of these desirable properties along with their conflicts is presented. 
 
Desirable properties Conflict 
Small sensor The size of sensor is definitely an important factor, 
especially for portability and mobility matters. However, 
small sensors may not have enough room for long-lasting 
battery or storage capacity. 
Smart sensor Sensors possessing many characteristics are often bigger in 
size, expensive and consume more power 
Sensor storage capacity Due to a limit in storage capacity, sensors have to upload 
data frequently to the data personal server. So it is 
important to employ a good wireless communication 
technology that does not drain excessive power from the 
sensors. 
Sensor processing capability Because sensors do not often have large processing 
capability, they may not be able to process all data before 
the upload to the personal server. This means that large 
amount of raw data should be stored and eventually sent. 
Therefore it is important to have an efficient 
communication channel. 
Sensor communication range Whilst sensors are only able to communicate over short 
range, it is crucial to define a specific radius of action.  
Table 2. Wearable sensors desirable properties & conflicts 
3.2.1 Systems for Parkinson’s disease monitoring  
Most of the research work carried out in the field of PD monitoring focuses on the 
assessment of the motor status of PD’s patients. During the last decade, many research 
groups have been trying to develop a system able to objectively quantify the severity of the 
motor disturbances using motion sensors (Patel et al., 2010; 2009; 2007). An important 
number of these studies is based on the study of various parameters of motor behaviour, in 
particular features related to the gait (R. Greenlaw et al., 2009; Salarian et al., 2007; 2004).  
Other studies focused on the identification of ON/OFF fluctuations through the assessment 
of tremor (Van Someren et al., 1993), dyskinesias (Keijsers et al., 2003; 2000) and 
bradykinesia (Papapetropoulos et al., 2010). Some groups are also committed to use 
electromyogram (EMG) or voice analysis (Kimura et al., 2007). 
Additionally, in the literature there are examples of remote monitoring and patient 
management for PD (Tindall & Huebner, 2009), as well as the use of telematic services to 
facilitate the performance of motor tests remotely (Das, 2010; Dorsey et al., 2010; Giansanti et 
al., 2008; Westin et al., 2010). 
Even though many advances have been done in the last years, it must be said that there is 
still a lack of an all-inclusive system able to provide reliable assessment of the status of PD 
patients being at the same time economically affordable. In particular it is crucial to provide:  
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 An effective evaluation of PD symptoms through monitoring and testing routines while 
not interfering with the patient daily life. 
 A personalised profile of the patient allowing the correlation between those factors 
affecting the severity of symptoms (i.e. medication schedule and meals) and the 
evolution of the disease.  
 The clinician with a system able to manage more efficiently the patient by providing 
timely indications on the effectiveness of the therapy and suggestions on therapy 
changes. 
3.2.2 Available systems in the market/research 
There are several products produced by certain research groups or commercially available 
for the assessment of PD. Some examples follow: 
Cleveland Medical Devices 
Cleveland Medical Devices Inc. commercialises Kinesia, a compact wireless system for 
monitoring the severity of PD motor symptoms. The system includes miniature motion 
sensors worn on the hand and it wirelessly transmits motor symptom information to a 
personal computer. Data is collected while patients follow computer based video 
instructions. 
 
 
Fig. 1. Kinesia, Cleveland Medical Devices Inc. system for PD monitoring based on motor 
sensors (Jovanov et al., 2001) 
Cleveland Medical Devices Inc. also commercialises Kinetisense, a compact wireless system for 
monitoring gait, posture or upper limb movement. The system integrates two channel 
Electromyography (EMG) and three orthogonal accelerometers and gyroscopes collecting data 
on three dimensional movements. The system is wearable and lightweight and is wirelessly 
connected to a computer for real-time data transmission. As alternative, data can be stored on 
a memory card for 12 hours recording and transmitted asynchronously. The system can be 
linked to different software tools for movement and posture analysis, detection of slips and 
falls and for the performance and monitoring of rehabilitation exercises. 
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Fig. 2. Kinetisense, Cleveland Medical Devices Inc. system for PD monitoring based on 
motor sensors and electromyography (Jovanov et al., 2001) 
Intel Corporation 
Intel Corporation has developed a system called At home Telemonitoring Device (AHTD), 
based on nonlinear speech single processing methods around the use of discrete variational 
integrator. It could be used to perform speech analysis detect abnormalities and telemonitor 
neurological disorders with voice singles. 
 
 
Fig. 3. At Home Telemonitoring Device (AHTD), Intel Corporation system for PD 
monitoring based on speech processing (Tsanas et al., 2010b) 
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Karolinska Institute 
The Karolinska Institute, Sweden, has developed a prototype test battery for evaluating 
fluctuation motor symptoms in PD together with a decision support system as part of the 
Movistar TEVAL project (Westin et al., 2010). The system is based on a handheld device 
with built-in mobile communication, where combined patient diaries with on-screen motor 
tests are implemented. The data collected from the patient are transmitted to a central 
system where they are analysed through Artificial Intelligence methods. Besides, it 
originates alerts and advice via a web interface. 
 
 
Fig. 4. TEVAL project prototype, Karolinska Institute, Sweden, based on patient diaries 
together with on-screen motor tests 
Twente University 
The University of Twente, Enschede, in the Netherlands, has developed a system called 
SensorShoe that is a mobile gait analysis tool. It is composed by a low-power sensor node 
equipped with movement sensors (3D accelerometers and 2D gyroscopes) connected to a 
PDA which provides immediate feedback to the patient while walking and suggest physical 
 
 
Fig. 5. Sensor Shoe, University of Twente, Enschede, The Netherlands. Gait analysis based 
on movement sensors (Kauw-A-Tjoe et al., 2007) 
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exercises based on the personal rehabilitation and training program defined for the patient 
and stored in the PDA. The system can connect to the hospital or to the physician through 
the PDA and transmit daily motion data, which can be analysed by physicians and be used 
to improve the physical therapy.  
Federal Polytechnic School of Lausanne  
The Federal Polytechnic School of Lausanne, Switzerland, has developed a system for 
motion monitoring based on a portable data-logger with three body-fixed inertial sensors. 
 
 
Fig. 6. a) The trunk sensor used for physical activity monitoring b) The uni-axial gyroscopes 
used for the gait analysis, The Federal Polytechnic School of Lausanne, Switzerland 
(Salarian et al., 2007). 
 
 
Fig. 7. a) Trunk sensor used for physical activity monitoring b) The uni-axial gyroscopes 
used for the gait analysis, The Federal Polytechnic School of Lausanne, Switzerland 
(Salarian, et al., 2007b) 
Boston University 
The Boston University National Institute of biomedical Imagining and Bioengineering has 
developed a wearable-sensor system for monitoring motor function. The system is 
composed by a device that can be worn unobtrusively by patients in their home to 
automatically detect the presence and severity of movement disorders associated with PD. 
The onset of the OFF status is based on the motor status of the patient that can be related to 
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the motor status of the patient with the medications assumptions. The system involves 
electromyographic (EMG) and accelerometric (ACC) body worn sensors, whose signals are 
analysed by a system using Artificial Intelligence methods. 
 
 
Fig. 8. Boston University National Institute of Biomedical Imaging and Bioengineering, PD 
monitoring system through motor and EMG sensors (UB, 2011) 
3.3 Technological solution: non autonomous home based monitoring closed loop 
systems  
Close loop systems are those in which stimulation parameters are adjusted according to 
recorded signals. Talking about neurodegenerative diseases such as PD, close loop systems 
imply that medication doses and timing is adjusted based on the measurement of certain 
biomedical signals. Some examples follow. 
3.3.1 PERFORM project 
A sophisticated multi-paRametric system FOR the continuous effective assessment and 
Monitoring of motor status in Parkinson’s disease and other neurodegenerative diseases 
research project has developed an intelligent system that monitors several motor signals of 
the patients that are analyzed in a medical centre by a medical professional. The system is 
able to propose treatment changes, based on the clinical assessment. Further explanations 
are provided later in this chapter (Perform, 2008). 
3.3.2 HELP project 
The HELP project (Home-based Empowered living for Parkinson's Disease Patients) aims at 
developing a comprehensive system able to administer drug therapy without patient 
intervention, in either continuous or on-demand basis in order to manage disease 
progression and to mitigate PD’s symptoms (Help, 2011). 
It is based on inertial sensors that capture inertial information about the patient’s motion 
and compute spatiotemporal properties and Parkinson's related symptoms. At the point of 
care remote supervision of the patient is performed, together with Verification of the 
infusion algorithm and possible modification of its parameters. An intraoral device 
continuously administrates dopamine agonists to the mucosa from the mouth. Besides, a 
subcutaneous pump receives commands adapting the infusion rate of apomorphine, a non-
selective dopamine agonist. 
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4. PERFORM system  
4.1 Introduction 
PERFORM is a project partially funded by the European Commission under the Seventh 
Framework Program, aiming at providing an innovative and reliable tool that is able to 
monitor and evaluate motor neurodegenerative disease patients, such as PD patients. 
The PERFORM project is based on the development of an intelligent closed loop system that 
seamlessly integrates a wide range of wearable micro-sensors constantly monitoring several 
motor signals of the patients. Data acquired are pre-processed by advanced knowledge 
processing methods, integrated by fusion algorithms to allow health professionals to 
remotely monitor the overall status of the patients, adjust medication schedules and 
personalize treatment. Personalization of treatment occurs through PERFORM‘s capability 
to keep track of the timing and doses of the medication and meals that the patient is taking. 
4.2 The PERFORM medical and technological vision 
The information gathered by the inertial sensors (accelerometers and gyroscopes) is 
processed by several classifiers. As a result, it is possible to evaluate and quantify the PD 
symptoms that the patient presents as well as analyze the gait of the patient. Based on this 
information, together with information derived from tests performed with tests devices (e.g. 
virtual reality gloves) and information about the medication and food intake, a patient 
specific profile is built. Next steep is to compare the patient specific profile with his 
evaluation during the last week and last month, checking whether his status is stable, 
improving or worsening. Based on that, the system analyses whether a medication change is 
needed-always under medical supervision- and in this case, information about the 
medication change proposal is sent to the patient. 
 
Monitor
Patient
Test Devices
Other Info
Detect & Quantify
Symptoms & Gait Build
Patient Specific
disease profile
Assess
Disease Progress
Suggest
Treatment Changes
New Treatment
Regime
 
Fig. 9. PERFORM medical and technological vision 
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4.3 The PERFORM architecture  
The system architecture proposed to meet the previously described medical and 
technological vision is presented in Fig. 10. It consists of two subsystems: the patient-side 
subsystem and the healthcare centre subsystem. 
 
Local Base Unit
Logger
User-
Hardware
Interface
Fall Detector
Alert 
Manager
Device
Controller
Test Processor
Scheduler
In
fo
rm
a
ti
o
n
 H
a
n
d
le
r
Freezing of Gait
Gait
Tremor
LID
Activity
BradykinesiaRepository
Wearable
Sensors
Communicator
Clinician
Administrator
External Resources
C
e
n
tr
a
l U
n
it
 C
o
m
m
u
n
ic
a
to
r
PERFORM
Repository
Interoperability Manager
C
e
n
tr
a
l U
n
it
 In
fo
rm
a
ti
o
n
 H
a
n
d
le
r
User DB
Login Manager Account Manager
Permitted Access Level
Alert  Manager
Index of Processed InfoPatient List
Clinical Decision Support Systems
Patient Modelling
Gait 
On – Off 
LID 
Tremor 
Bradykinesia
Early Wearing Off 
Medication Change 
Stability-Worsening 
Patient Management
Action Tremor
Patient GUI
2
Patient-Side Subsystem
Health Care Centre Subsystem
Test 
Devices
Central Hospital Unit
Professional GUI
Frequent Falls
 
Fig. 10. PERFORM system architecture (R. Greenlaw et al., 2009) 
The patient-side subsystem is responsible for the identification and quantification of the 
patient symptoms and the recording of other useful information for the evaluation of the 
patient status. The healthcare centre subsystem evaluates the disease progression and 
suggests appropriate treatment and changes, based on medical knowledge acquired from 
published medical guidelines.  
The patient-side subsystem is composed by the following modules: 
Continuous monitoring Module. It is used to monitor the patient motor status through the 
day. It consists of five accelerometers and a wearable device. The wearable device processes 
the recorded signals and detects patient falls in real time. The sensors position was hosen 
after careful examination and research on the targeted disease symptoms. 
It is composed of four tri-axial accelerometers used to record the accelerations of the 
movements at each patient extremity, one accelerometer and gyroscope (on the trunk) used 
to record body/chest movement accelerations and angular body velocity during trunk and 
body turning, and a wearable device receiving all recorded signals. The sensors‘ position 
was chosen to allow all targeted symptoms detection and quantification with the minimum 
number of sensors.  
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Fig. 11. PERFORM System prototype including accelerometers, gyroscope and data logger 
(left) System placement on the body (right) 
All sensors transmit using Zigbee protocol to the wearable device which is located on the 
patients’ waist thus making up a body sensor network. Special attention is given to the 
sensors usage and the easy set up by the patient and the caregivers. The sensor size is no 
bigger than a small matchbox. Sensors on the arms and legs are attached on specially 
designed elastic Velcro bands, which allow fixation to any wrist or ankle size. The sensors 
are placed inside an elastic pocket on the band, which secures it firmly on the patient body 
avoiding motion artefact due to cloth movement. The sensor on the trunk in placed within a 
zipped elastic pocket on a vest. The vest is also equipped with Velcro straps to firmly adjust 
the sensor on the patient chest. The selected design allows the easy wearing and 
attachment/detachment of sensors. 
Test Module. It consists of a set of devices (such as virtual reality gloves, microphones or 
video cameras) used to record patient information, while the patient is performing specific 
tests, as normally done at the clinician’s office during an examination. The patient wears the 
test devices and performs the tests as instructed from the visual interface of the Base Module 
(Local Base Unit). The test module records the performed activities and identifies any 
abnormalities, such as wrong sensor or patient position. Finally, it processes the recorded 
data and extracts the information about the number of taps and hand movements per 
second, the detection of hypophonia and neutral face expression. 
Patient interface. Emphasis is given in designing an easy to use interface for the patient, 
considering the patient motor disabilities and limited computer familiarity. The designed 
interface inherits the feel and tough of the phone dialling pad, and all system choices are 
based on it. Patient use the interface to declare their subjective estimation of their own 
status, to gain access to relevant disease information, to receive instructions on life-style 
interventions, such as medication and good intake and on the execution of tests. Moreover, 
PD’s patients declare medication intake information, which is useful for the patient status 
assessment. 
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Fig. 12. PERFORM Patient Interface. Medication intake information (left). Food intake 
information (right) 
Communication: the Base Module supports Bluetooth and Zigbee communication with the 
continuous monitoring system, and fixed line communication to the hospital centre over 
ISDN and xDSL. 
Symptom Detection. This submodule processes received patient signals and detects the 
targeted patient symptoms (tremor, levodopa induced dyskinesia and off state). For each 
symptom dedicated submodule processes the relevant signals, detests the symptom episode 
and quantifies it into a severity scale from 1 to 4, according to the UPDRS scaling for PD 
patients (Cancela et al., 2010; Keijsers et al., 2000; Pansera et al., 2009). Other features such as 
duration, frequently and amplitude might also be provided for further clinician review and 
system evaluation. 
The healthcare centre subsystem is composed of the following modules: 
Patient Modelling Module. This module exploits the recorded patient information to build 
a patient symptom profile. For each main symptom (tremor, levodopa induced dyskinesia 
and on-off states), it produces a patient profile which describes the patient’s common 
symptom features. When a new patient recording is processes, it is checked against the 
patient symptom profile. If significant differences are found, it might be due to two reasons: 
either a temporarily patient behaviour abnormality or a change to the patient profile. In the 
last case, the system checks whether a substantial number of similar situations are identified 
for the last time period for the specific patient and if that occurs, it creates an alert. 
Patient Management Module. This module considers the detected symptoms and their 
characteristics, combines them with other recorded information and suggests appropriate 
treatment changes based on the accumulated specialists’ knowledge on the management of 
PD. 
Medical Interface: The system can be accessed either locally or remotely by the treating 
clinician and the general practitioner, using either a large screen access device (e.g. PC, 
laptop) or a small screen access device (e.g. PDA). Clinicians are directed to the home 
system screen, which presents the produced patient alerts to the patient specific screen, 
which provides the information needed to evaluate visually the patient condition. On 
request, the actual recorded signal and tests are downloaded from the patient-side to the 
healthcare centre for review. The focus is on the provision of an adequate visual description 
of the patient status within one screen, minimising the time spend by a clinician. Clinicians 
will access the system periodically to check patient status, but the option to be alerted when 
patient status changes are also available. 
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Fig. 13. PERFORM medical interface 
Communication. All patient-side data (signal features and patient inserted information) are 
transmitted to the health-care subsystem once a day, through Internet. 
4.4 Evaluation methodology 
In order to test PERFORM system, several clinical trials have been arranged into 4 different 
phases, taking place between 2009 and 2011. Their description follows.   
Phase 1: Data collection with SHIMMER 
Eight subjects participated in this study, separated in two groups: four PD patients and four 
healthy subjects. The symptoms were rated by a professional neurologist with more than 20 
years of experience with PD patients. Four accelerometers were placed on the right and left 
forearms and on the right and left calves, with a fifth accelerometer being placed on the 
trunk, at the base of the sternum. Motion data was collected using the SHIMMER platform 
(RealTime, 2011). SHIMMER is a small wireless sensor platform designed by Intel as a 
wearable device for health sensing applications. All sensors provide 3-axis accelerometer 
signals large storage, and low power-standards based communication capabilities. They also 
provide a Bluetooth protocol capability that allows SHIIMERs to stream the data to a 
computer. During the experiment, the accelerometry measurements were complemented by 
a reflective marker and a camera collection system. This complimentary analysis served as a 
support tool to validate the data used for this work. 
Phase 2: Data Collection with ANCO first release trainer classifier 
The data collection was performed with a network of wireless 3-axis ALA-6g sensors (Anco, 
2011), located on the limbs, trunk and belt of the patient. During this phase, data were 
collected during tests with patients in a supervised environment, with the collaboration of 
the clinic’s medical staff. Patients involved in this phase were required to be aged between 
18 and 85 years old, suffering from PD, capable of complying with study requirements, 
receiving dopaminergic treatment and experiencing motor fluctuations. Dementia, 
Psychosis and significant systemic diseases (such as cancer) were the exclusion criteria 
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applied when selecting participants. The data set used in this study included trials with 
twenty PD patients, ten in Navarra (Spain) and ten in Ioannina (Greece). In order to comply 
with ethical requirements, all procedures were carried with the Clinic Institutional Review 
Board’s permission. Data were collected following a standard clinical protocol in which 
patients carried out daily basic activities (i.e. walking, lying, sitting, etc.) during two cycles 
of on-off oscillations in response to levodopa during the same day and under the 
supervision of a clinician. 
Phase 3: Long time recording 
Data collection of phase 3 was performed with an updated version of the devices that 
includes a wearable and programmable logger that gave a better mobility to the patient and 
new ALA-6g accelerometers sensors equipped with an external battery allowing longer data 
collection session. Data were collected in a supervised environment and with the 
collaboration of the medical staff. Furthermore, patients involved in this phase, fulfilled 
with the age and medical specifications of the previous phase. The data were recorded with 
twenty-four PD patients, twelve in Navarra and twelve in Ioannina. Data were collected 
during a six-hour daily session in which patients carried out their normal daily activity. 
Moreover, four standard clinical protocol sessions were performed during two cycles of on-
off oscillations in response to levodopa treatment and under the supervision of a clinician. 
At the end of the day, data were processed using the train set computed in the previous 
phase and the output were checked with the results provided by the clinicians  
Phase 4: Final system testing 
From March 2011, the integrated and final PERFORM system will be introduced to a new 
group of patients that will perform the final evaluation. The patient group will be 
constituted by 20 PD patients for regular tests and 4 PD patients for mid-term tests, all 
recruited from the Neurology Department from the Azienda Unita’ Sanitaria Locale di 
Modena hospital in Modena, Italy. 
4.5 Results 
PERFORM project has released promising results in patients monitoring and status 
assessment. Due to the short-term nature of the clinic trials that have been carried out it is 
difficult to determine the future impact on patient treatment; however it is possible to at 
least provide a quantification of the performances of the modules of the Patient –Side 
Subsystem. It is designed to assess the motor status of the patients and establish a direct 
connection with the physician. Its basic functions are: 
 to determine the activity of the subject 
 to provide a quantification of symptoms severity based on the UPRDS scale and present 
such an information to the physician through remote communication 
 to gather information about the daily life of the patient 
The validation has proved that the first prototype of the Patient Side Subsystem is able to 
provide a very reasonable assessment of the daily activity of the patients using data 
classification techniques based on accelerometers. More specifically, the algorithms are able 
to discriminate activities such as walking, standing, laying or sitting with an accuracy of 
nearly 99%. The activity recognition is the base information needed to evaluate the 
symptoms related to movement. Besides, the clinical trials have proved that the algorithms 
are able to classify with an acceptable degree of accuracy the main symptoms of PD. General 
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body bradykinesia is quantified with a classification accuracy within the range of 70%-86% 
(depending on the number of sensors used in the measurements) compared to medical 
evaluation. Dyskinesia and tremor classification accuracy are respectively 93.6% and 97%. 
Those results are quite good in comparison with the subjective medical evaluation, with 
accuracy around 95%. The gait module has also proved to release useful information with 
acceptable level of accuracy. The gait analysis system provides a measure of stride length 
with a 7.3% of average error and a measurement of the complexity of movement through an 
analysis of the entropy of the walking.  
Phase IV of the pilots is expected to provide a more accurate validation with long-term 
recording data. 
4.6 Comparison with SoA systems 
Compared to Kinesia system, a sophisticated multi-paRametric system FOR the continuous 
effective assessment and Monitoring of motor status in Parkinson’s disease and other 
neurodegenerative diseases (PERFORM) presents the advantage of integrating other data 
from patient’s monitoring, such as data from normal daily activity Kinesia monitors only 
upper extremity motor symptoms, while PERFORM is able to monitor the entire motor 
disorder, involving walking and moving in general, including freezing, falls risks, etc. The 
system is based on proprietary software and raw data may not be available. 
In relation to Kinetisense commercial product, PERFORM links motion monitoring data to 
other information such as medication assumption, stress situations and historic data of the 
patient, in order to draw a complete picture and not only a snapshot such as Kinetisense 
does. The system is based on proprietary software and raw data may not be available. 
PERFORM integrates more data from continuous monitoring rather than on e-diary and 
voluntary motion exercises as the TEVAL Movistar system does. 
Compared with SensorShoe system, PERFORM provides link to medication and enables 
complex data interpretation and analysis. On the other hand, PERFORM system is also able 
to detect abnormalities in motion, which the prototype built by the École Polytechnique 
Federale de Lausanne is not detecting.  
In comparison with the system proposed by Boston university, PERFORM manages data 
from more devices and is able to correlate different data input. 
Finally, in comparison with the project HELP, PERFORM is able to provide an assessment 
for specific symptoms such as dyskinesia, bradykinesia, tremor and akynesia, delivering a 
quantification based on the UPDRS scale, which HELP is not taking into consideration. On 
the other hand, the system is not providing a feedback to adjust the medication directly on 
the patients. In other word, PERFORM is not closing the loop of 
monitoring/assessment/medication adjustment in an automatic way, that is what HELP 
project has tried to do.  
5. Conclusions  
This chapter has presented a SoA review of the main methods used to monitor and assess 
PD’s patients. On one hand, clinical assessment is usually performed through annotations in 
diaries and self-reports from the patient during the short office visit in this neurologist the 
patient may appear very well and he misses to report some symptoms, as a result, treatment 
modifications are not undertaken in time. The UPDRS is a scale that tries to quantify 
selected symptoms and signs of Parkinsonism in a 5-points scoring system (with 0 for no 
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signal and 4 for a marked severity of the sign). Unfortunately, the UPDRS like any other 
semi-objective rating scale has limitations like intra and inter observer inconsistencies, can 
be time consuming and ca be biased by subjectivity issues related to historical information.  
On the other hand, technological solutions are able to provide quantitative objective 
information, including the use of motor sensors, electromyography, position transducers, 
and speech recognition systems. 
This chapter has presented PERFORM, a project partially funded by the European 
Commission under the 7th Framework Program, aiming at providing an innovative and 
reliable tool that is able to monitor and evaluate motor neurodegenerative disease patients, 
such as PD patients. 
The PERFORM project is based on the development of an intelligent closed loop system that 
seamlessly integrates a wide range of wearable micro-sensors, constantly monitoring several 
motor and signals of the patients. Data acquired are pre-processed by advanced knowledge 
processing methods, integrated by fusion algorithms to allow health professionals to 
remotely monitor the overall status of the patients and adjust medication schedules and 
personalize treatment. Personalization of treatment occurs through PERFORM‘s capability 
to keep track of the timing and doses of the medication and meals that the patient is taking. 
The system architecture has been presented. A comparison with available related systems 
has been performed. 
The system has already been tested in hospitals in Navarra (Spain) and Ioannina (Greece). 
The integrated tests of the system will be performed in Modena (Italy) from March 2011. 
Obtained results so far suggest an overall valid closed loop system, able to detect PD 
symptoms based on motor signals and additional information, evaluate with a high 
accuracy level the overall status of the patient and propose medication changes accordingly. 
However, to achieve more improvements especially in the automation of close-loop 
mechanism, further improvements are needed in order to provide a complete reliable 
assessment system for symptoms severity.  
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